Q1 EPS Estimates for Core Scientific Cut by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZ) – Research analysts at Roth Capital lowered their Q1 2025 EPS estimates for Core Scientific in a report released on Wednesday, April 9th. Roth Capital analyst D. Aftahi now expects that the company will earn ($0.14) per share for the quarter, down from their prior forecast of ($0.11). The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific’s Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.43) EPS and Q1 2026 earnings at ($0.02) EPS.

Core Scientific (NASDAQ:CORZ) last posted its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.09. The business had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million.

Several other analysts have also weighed in on the company. BTIG Research increased their price target on Core Scientific from $19.00 to $20.00 and gave the company a “buy” rating in a report on Monday, December 16th. Keefe, Bruyette & Woods initiated coverage on shares of Core Scientific in a research note on Monday, January 27th. They set an “outperform” rating and a $22.00 price target for the company. Needham & Company LLC reduced their price objective on shares of Core Scientific from $18.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, February 27th. Canaccord Genuity Group restated a “buy” rating and set a $17.00 target price on shares of Core Scientific in a research report on Wednesday, March 12th. Finally, Cantor Fitzgerald decreased their price target on Core Scientific from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Fifteen equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Core Scientific has an average rating of “Buy” and a consensus target price of $19.07.

Core Scientific Price Performance

Shares of NASDAQ CORZ opened at $7.06 on Monday. The stock has a market capitalization of $2.08 billion, a P/E ratio of -1.30 and a beta of 6.80. The business’s 50 day moving average is $9.28 and its two-hundred day moving average is $12.69. Core Scientific has a 1-year low of $2.61 and a 1-year high of $18.63.

Institutional Investors Weigh In On Core Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC acquired a new position in shares of Core Scientific during the third quarter worth $2,903,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Core Scientific during the 3rd quarter valued at about $2,651,000. Janus Henderson Group PLC acquired a new position in Core Scientific during the 3rd quarter valued at about $706,000. State Street Corp boosted its holdings in Core Scientific by 17.0% in the third quarter. State Street Corp now owns 4,006,922 shares of the company’s stock worth $47,522,000 after acquiring an additional 583,493 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Core Scientific by 26.7% during the third quarter. Geode Capital Management LLC now owns 5,276,573 shares of the company’s stock worth $62,594,000 after acquiring an additional 1,113,285 shares during the last quarter.

Insider Activity

In related news, Director Todd A. Becker sold 134,250 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now owns 195,687 shares of the company’s stock, valued at $2,103,635.25. This trade represents a 40.69 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Todd M. Duchene sold 25,277 shares of the stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $16.24, for a total transaction of $410,498.48. Following the sale, the insider now directly owns 2,023,423 shares of the company’s stock, valued at approximately $32,860,389.52. The trade was a 1.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 530,041 shares of company stock worth $7,870,352. Corporate insiders own 32.00% of the company’s stock.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.